Coagulase-negative Staphylococcus bacteraemia: Prognosis factors and influence of antibiotic treatment;Bacteriemias por staphylococcus coagulasa negativa: Análisis de factores pronóstico e influencia del tratamiento antibiótico

Revista Espanola de Quimioterapia

Volumn 25, Issue 3, 2012, Pages 199-205

  Fernández Rufete, Ana ^a   García Vázquez, Elisa ^a,b   Hernández Torres, Alicia ^a   Canteras, Manuel ^b   Ruiz, Joaquín ^a   Gómez, Joaquín ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Bacteraemia; Coagulase negative staphylococcus; Mortality; Treatment

Indexed keywords

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CENTRAL NERVOUS SYSTEM INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; DISEASE SEVERITY; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MORTALITY; NONHUMAN; PACEMAKER; PERSISTENT INFECTION; PROGNOSIS; PROSPECTIVE STUDY; SEPSIS; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COAGULASE; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 84868528310     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (Suppl. 16):72-5.
2. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA 1991; 265:365-9.
3. Souvenir D, Anderson DE Jr, Palpant S, Mroch H, Askin S, Anderson J et al. Blood cultures positive for coagulase-negative Staphylococci: Antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998; 36:1923-6.
4. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 1994; 19:231-43.
5. Ponce de Leon S, Wenzel RP. Hospital-Acquired Bloodstream Infections with Staphylococcus epidermidis. Review of 100 cases. Am J Med 1984; 77:639-44.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
7. McCabe WR, Jackson GG. Gram negative bacteraemia. I. Etiology and Ecology. Arch Intern Med 1962; 110:847-55.
8. Winston DJ, Murphy W, Young LS, Hewitt WL. Piperacillin Therapy for serious bacterial infections. Am J Med 1980; 69:255-61.
9. Sanz Carabaña P, Ramos Martínez A, Asensio Vegas A, García Navarro MJ, Linares Rufo M. Mortalidad y factores pronósticos en pacientes hospitalizados por bacteriemia adquirida en la comunidad. Anal Med Interna 2006; 23:66-72.
10. Jacobs ER, Bone RC. Clinical indicators in sepsis and septic adults' respiratory distress syndrome. Med Clin North Am 1986; 70:921-32.
11. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002; 51(RR-10):1-36.
12. Fidalgo S, Vázquez F, Mendoza MC, Pérez F, Méndez FJ. Bacteremia due to S. epidermidis: Microbiologic, Epidemiologic, Clinical and Prognostic features. Rev Infect Dis 1990; 12:520-27.
13. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989; 1:34-46.
14. Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R. Non-epidermidis coagulase-negative staphylococcal bacteremia: clinical predictors of true bacteremia. Eur J Microbiol Infect Dis 2004; 23:495-8.
15. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Ann Intern Med 1980; 68:332-43.
16. Dender JW, Hughes WT. Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Med J 1980;146:13-5.
17. Christensen D, Blasao AL, Parisi JT, McLaughlin B, Hester MG, Luther RW. Nosocomial septicemia due to multiple antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med 1982; 96:1-10.
18. Gómez J, Baños V, Hernández A. Bases para optimizar el uso prudente y adecuado de antibióticos en la clínica práctica. En (Gómez J, Gobernado M Eds). Enfoque Clínico de los Grandes Síndromes Infecciosos. Madrid. Ergón Ed. 4a Edición 2011.
19. Fajardo M, Hidalgo R, Rodríguez S, Garduno E, Rodríguez FF, Robles M. Actividad de daptomicina, ciprofloxacino, clindamicina y cotrimoxazol frente a diferentes cepas de Staphylococcus coagulasa negativo con sensibilidad conservada y disminuida para vancomicina. Rev Esp Quimioter 2010; 23:81-8.
20. Soriano A, Macro F, Martínez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomycin minimum inhibitory concentration on the treatmen of methicillin resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:193-200.
21. Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, et al. Relationship between vancomycin MIC and failure among patients with MRSA bacteremia treated with vancomycin. Antimicrob Agent Chemother 2008; 52:3315-20.